Vita Life SciencesASX:VLS 94 Forward Dividend Yield % is 5.60% as of Jun. 25, 2026. GuruFocus rates ASX:VLS with a GF Score™ of 94/100 and a GF Value™ of A$2.47 (Fairly Valued). The stock has 1 warning sign investors should review. Among 504 Drug Manufacturers companies, Vita Life Sciences ranks better than 89.88% on this metric.
As of today (2026-06-25), the Forward Annual Dividend Yield of Vita Life Sciences is 5.60%.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Vita Life Sciences is 5.60%.
ASX:VLS's Forward Dividend Yield % is ranked better than 89.88% of 504
companies
in the Drug Manufacturers industry
Industry Median: 2.095
vs ASX:VLS: 5.60
During the past 12 months, Vita Life Sciences's average Dividends Per Share Growth Rate was 15.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 23.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 22.30% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 11.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Vita Life Sciences was 91.30% per year. The lowest was 0.00% per year. And the median was 16.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Vita Life Sciences (ASX:VLS) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Vita Life Sciences Forward Dividend Yield % Related Terms
ASX:VLS vs ZTS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vita Life Sciences Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Vita Life Sciences's Forward Dividend Yield % falls into.
Vita Life Sciences Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Vita Life Sciences Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.095000
2026-03-27
2026-03-30
2026-04-10
Cash Dividend
semi-annually
AUD:AUD 1.000000
AUD 0.045000
2025-09-19
2025-09-22
2025-10-03
Cash Dividend
semi-annually
AUD:AUD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Vita Life Sciences's Forward Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 5.60% mean?
Vita Life Sciences (ASX:VLS) has a Forward Dividend Yield % of 5.60% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Vita Life Sciences and its competitors. According to the industry distribution chart, Vita Life Sciences ranks #51 out of 504 companies in the Drug Manufacturers industry, placing it in the top 10.1%.
Is Vita Life Sciences' Forward Dividend Yield % too high?
Vita Life Sciences' current Forward Dividend Yield % is 5.60%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. Vita Life Sciences' value of 5.60% is 167.3% above this industry median. Based on the distribution chart, Vita Life Sciences ranks #51 out of 504 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vita Life Sciences has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vita Life Sciences' Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vita Life Sciences ranks #51 out of 504 companies for Forward Dividend Yield %. This places Vita Life Sciences in the top 10% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.10. Vita Life Sciences' value of 5.60% is 167.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vita Life Sciences's current Forward Dividend Yield % of 5.60% is 167.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Vita Life Sciences and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vita Life Sciences's current Forward Dividend Yield % is 5.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vita Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Vita Life Sciences (ASX:VLS) is currently considered Fairly Valued. The stock's GF Value™ is A$2.47, compared to a current price of A$2.50 — trading 1.2% above its estimated fair value. The current Forward Dividend Yield % is 5.60% and 167.3% above the Drug Manufacturers industry median of 2.10. Vita Life Sciences' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Vita Life Sciences (ASX:VLS), the current Forward Dividend Yield % is 5.60% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vita Life Sciences (ASX:VLS) Overvalued in 2026?
Based on GuruFocus' analysis, Vita Life Sciences stock appears to be overvalued.
The current stock price of A$2.50 is trading 1.2% above its estimated GF Value™ of A$2.47.
GuruFocus considers Vita Life Sciences to be Fairly Valued.
Key valuation signals for ASX:VLS:
Forward Dividend Yield %: 5.60%
GF Value™: A$2.47 vs. price of A$2.50 (1.2% above fair value)
Industry Position: 167.3% above the Drug Manufacturers median (#51 of 504)
No single metric tells the full story. See the ASX:VLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.
94GF Score
Get the complete analysis for ASX:VLS
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VLS has been successfully added to your 